Human Health Holdings Limited (HKG:1419)

Human Health Holdings Balance Sheet

Financials in millions HKD. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	523.53	439.9	489.58	641.26	270.33
Cash & Short-Term Investments	523.53	439.9	489.58	641.26	270.33
Cash Growth	19.01%	-10.15%	-23.65%	137.21%	66.02%
Accounts Receivable	49.64	62.45	43.7	101.63	422.34
Other Receivables	2.45	20.11	23.3	2.11	-
Receivables	52.09	94	67	103.74	422.34
Inventory	18.89	25.08	32.28	28.33	18.33
Prepaid Expenses	33.35	27.64	23.73	22.66	18.89
Other Current Assets	1.03	1.03	1.02	1.01	2.05
Total Current Assets	628.88	587.65	613.61	796.99	731.93
Property, Plant & Equipment	198.54	222.37	206.42	221.86	224.38
Long-Term Investments	113.22	129.03	117.06	106.6	95.59
Goodwill	54.65	54.65	31.96	31.96	31.96
Other Intangible Assets	24.68	25.86	2.16	3.77	5.38
Long-Term Deferred Tax Assets	9.93	6.34	2.84	2.41	4.94
Other Long-Term Assets	24.46	46.07	71.08	88.55	64.44
Total Assets	1,067	1,072	1,056	1,263	1,159

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	57.27	68.51	49.79	55.1	38.58
Accrued Expenses	3.24	22.65	26.58	40.3	41.7
Short-Term Debt	35.94	16.83	31.54	36.51	42.22
Current Portion of Leases	52.86	49.01	49.02	48.13	39.25
Current Income Taxes Payable	6.94	3.02	10.69	98.63	96.18
Current Unearned Revenue	12.85	17.15	20.77	29.11	5.72
Other Current Liabilities	38.36	26.56	27.44	41.41	37.46
Total Current Liabilities	207.48	203.72	215.82	349.18	301.09
Long-Term Leases	44.52	68.71	65.9	97.85	107.01
Long-Term Deferred Tax Liabilities	5.62	5.33	0.43	0.62	0.89
Other Long-Term Liabilities	14.34	12.46	7.56	7.62	7.68
Total Liabilities	271.95	290.22	289.71	455.27	416.67

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	3.8	3.8	3.8	3.8	3.8
Additional Paid-In Capital	-	190.22	190.22	190.22	190.22
Retained Earnings	-	567.75	552.04	588.54	519.67
Comprehensive Income & Other	790.8	19.99	20.61	25.66	28.26
Total Common Equity	794.6	781.75	766.67	808.22	741.95
Shareholders' Equity	794.6	781.75	766.67	808.22	741.95
Total Liabilities & Equity	1,067	1,072	1,056	1,263	1,159

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	133.32	134.54	146.46	182.49	188.47
Net Cash (Debt)	390.21	305.36	343.12	458.77	81.86
Net Cash Growth	27.79%	-11.00%	-25.21%	460.41%	-14.51%
Net Cash Per Share	1.03	0.80	0.90	1.21	0.22
Filing Date Shares Outstanding	379.55	379.55	379.55	379.55	379.55
Total Common Shares Outstanding	379.55	379.55	379.55	379.55	379.55
Working Capital	421.41	383.93	397.79	447.81	430.84
Book Value Per Share	2.09	2.06	2.02	2.13	1.95
Tangible Book Value	715.27	701.24	732.55	772.49	704.6
Tangible Book Value Per Share	1.88	1.85	1.93	2.04	1.86
Buildings	-	18.79	13.29	12.32	12.32
Machinery	-	112.52	103.95	81.39	55.52
Leasehold Improvements	-	83.99	77.45	75.28	35.89

Data Source: S&P Global Market Intelligence Last updated: Sep 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 13, 2026

Data Sources Report a data error